BIOMARIN PHARMACEUTICAL INC Payments to Acquire Marketable Securities
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Payments to Acquire Marketable Securities of $0 for the 12-month period ending 2010-12-31, per its 10-K filed 2011-02-24.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2011-02-24
- BIOMARIN PHARMACEUTICAL INC payments to acquire marketable securities for the quarter ending 2010-12-31 was $0.00.
- BIOMARIN PHARMACEUTICAL INC payments to acquire marketable securities for the quarter ending 2010-09-30 was $0.00.
- BIOMARIN PHARMACEUTICAL INC payments to acquire marketable securities for the quarter ending 2009-12-31 was $0.00.
- BIOMARIN PHARMACEUTICAL INC payments to acquire marketable securities for the quarter ending 2009-09-30 was $0.00.
- BIOMARIN PHARMACEUTICAL INC payments to acquire marketable securities for fiscal 2010 was $0.00, a 100.00% decline from fiscal 2009.
- BIOMARIN PHARMACEUTICAL INC payments to acquire marketable securities for fiscal 2009 was $6.25M, a 9.86% increase from fiscal 2008.
- BIOMARIN PHARMACEUTICAL INC payments to acquire marketable securities for fiscal 2008 was $5.69M.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-24 | $0.00 derived: sum of 2 quarters · filed 2011-02-24 | $0.00 10-K · filed 2011-02-24 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-29 | $0.00 10-Q · filed 2010-10-29 | ||
| 2010-06-30 | $0.00 10-Q · filed 2010-08-04 | |||
| 2009-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-24 | $0.00 derived: sum of 2 quarters · filed 2011-02-24 | $6.25M 10-K · filed 2011-02-24 | |
| 2009-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-29 | $6.25M 10-Q · filed 2010-10-29 | ||
| 2009-06-30 | $6.25M 10-Q · filed 2010-08-04 | |||
| 2008-12-31 | $5.69M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |